Latest news with #RocketDoctor
Yahoo
28-05-2025
- Business
- Yahoo
Treatment.com AI and Rocket Doctor Celebrate Recognition from UC Berkeley, Harvard, and AARP for Leadership in Health Innovation
From classrooms to conferences, Rocket Doctor earns national spotlight for transforming virtual care delivery ●These accomplishments further position Rocket Doctor as a trusted, physician-led innovator in digital health, committed to reaching underserved communities with smarter, tech-enabled care. ●At UC Berkeley's Health Engine, Rocket Doctor was selected as part of a competitive, non-dilutive accelerator focused on high-impact healthcare startups. ●At Harvard University, Dr. Cherniak was invited by Halle Tecco to speak to medical and business students about how Rocket Doctor is transforming healthcare delivery through virtual care, AI, and connected devices. ●At the AARP AgeTech Conference, Dr. Cherniak shared Rocket Doctor's approach to improving care for Medicaid and Medicare patients across the U.S., emphasizing the platform's role in addressing access, equity, and scalability for older adults. TORONTO, ON, May 28, 2025 (GLOBE NEWSWIRE) -- AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') and its wholly owned virtual care platform, Rocket Doctor, are proud to announce that the company has recently been recognized by three of the most prestigious organizations in healthcare innovation: UC Berkeley's Health Engine, Harvard University, and the AARP AgeTech Accelerator. These distinctions reinforce Rocket Doctor's position as a leading voice in comprehensive virtual care and demonstrate growing recognition of its physician-led, tech-driven model for transforming access to healthcare. It also further underscores Rocket Doctor recently being awarded Clinical Innovator of the Year at the American Telemedicine Association's NEXUS 2025 Innovators Challenge. As part of UC Berkeley's Health Engine accelerator, Rocket Doctor joined a select cohort of healthtech founders building impactful solutions to today's most pressing healthcare challenges. The non-dilutive, remote-first program provided expert mentorship, academic partnership, and strategic support to help accelerate mission and vision, gaining access to some of the world's leading faculty in health policy and digital health, and further boosting its integration into the California ecosystem. Following the Health Engine program, Dr. Cherniak was invited to speak at Harvard University, guest lecturing in a course led by Halle Tecco, course Director at Harvard Medical School, Adjunct Professor at Columbia Business School, and founder of Rock Health. During the session, Dr. Cherniak shared the Rocket Doctor journey, detailing how the platform empowers physicians with AI-enabled tools and diagnostic devices to deliver care efficiently, virtually, and at scale, answering questions from the class and engaging in discussions around health policy and digital innovation. Dr. Cherniak was also invited to speak at the 2025 AARP AgeTech Conference, part of the AgeTech Collaborative™ from AARP, where he shared the Rocket Doctor story with a national audience of entrepreneurs, investors, and healthcare leaders. His presentation highlighted the company's innovative approach to delivering comprehensive physician-led care, with a particular focus on supporting Medicaid and Medicare patients across the United States. As part of the conference's thought leadership programming, Dr. Cherniak outlined how Rocket Doctor is using technology to reduce barriers to care, streamline access for underserved populations, and addressing the complex needs of aging Americans through scalable, virtual-first models. 'It's an incredible privilege to engage with institutions like UC Berkeley, Harvard, and AARP - each of which plays a vital role in shaping the future of healthcare,' said Dr. William Cherniak, CEO of Rocket Doctor. 'Being selected and invited by these organizations is a strong validation of our vision to make high-quality care radically more accessible through technology, AI, and physician leadership.' Through these platforms, Rocket Doctor continues to build meaningful relationships with innovators, researchers, and decision-makers across the health ecosystem, further accelerating its mission to transform care delivery in North America and beyond. About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that empowers doctors to build and manage their own virtual or hybrid practices. Its proprietary software and AI-powered tools enable providers to deliver high-quality comprehensive care remotely, with a focus on reaching underserved and remote communities across North America. By removing barriers to care and restoring physician autonomy, Rocket Doctor is redefining what modern healthcare looks like. Visit or contact media@ About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at: or contact info@ FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO – AI Inc. Email: ehamza@ Media inquiries: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although AI believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Globe and Mail
27-05-2025
- Business
- Globe and Mail
Treatment.com AI Grants Stock Options and RSUs
VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') announces that it has granted an additional 633,589 restricted share units (' RSUs ') and 330,132 stock options (' Options ') to continuing employees and consultants of Rocket Doctor Inc., the Company's wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each exercisable for one common share of the Company at an exercise price of C$0.50 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All Options and RSUs are subject to the terms of the Company's equity plans and applicable securities law hold periods. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities.
Hamilton Spectator
20-05-2025
- Health
- Hamilton Spectator
REPEAT: Rocket Doctor Partners with Melanoma Canada to Expand Access to Follow-Up Care for At-Risk Patients
New collaboration will connect patients flagged during mobile skin cancer screenings with Rocket Doctor physicians across Ontario, Alberta, and British Columbia ●Rocket Doctor has partnered with Melanoma Canada to provide timely follow-up care for patients identified as at-risk during mobile skin cancer screenings. ●Patients without a family doctor will be directly referred to physicians on Rocket Doctor through a streamlined digital intake process. ●The Mole Mobile campaign travels across Alberta, British Columbia, Ontario, and Quebec, providing free screenings in both remote and urban communities. ● Skin cancer is the most common cancer in Canada, with 1 in 3 cancer diagnoses being skin-related — more than breast, prostate, lung, and colon cancers combined. ● 22 Canadians are diagnosed with melanoma every day, and 3 Canadians die daily from this serious form of skin cancer. ●The partnership is expected to increase patient visits on Rocket Doctor's platform, improving access to care and continuity for at-risk individuals. Toronto, ON, May 20, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') is proud to announce that its virtual care subsidiary, Rocket Doctor Inc., has partnered with Melanoma Canada to help bridge the care gap for individuals identified as at-risk for melanoma and other skin cancers during mobile screening events across the country. Melanoma Canada's Mole Mobile units, Canada's first mobile skin cancer screening clinics, presented by Neutrogena®, a Kenvue brand travel across Alberta, British Columbia, Ontario, and Quebec, offering free skin checks from certified dermatologists in both remote and urban communities. Through this partnership, Rocket Doctor will provide patients who do not have a family physician with timely access to follow-up appointments via its virtual care platform. 'Too many Canadians are going without the care they need simply because they don't have a family doctor,' said Dr. William Cherniak, Founder and CEO of Rocket Doctor. 'By partnering with Melanoma Canada, we're making it easier for patients identified during these critical screenings to get connected to a physician quickly, ensuring no one falls through the cracks.' Dermatologists working in the Mole Mobile units will complete an on-site risk assessment and referral form for patients who require follow-up. These forms can then be uploaded directly to Rocket Doctor's intake system, enabling efficient, streamlined review and timely access to appropriate care. The need for follow-up care has never been more urgent. Skin cancer is the most commonly diagnosed cancer in Canada, more prevalent than breast, prostate, lung, and colon cancers combined. One in every three cancers diagnosed in Canada is a skin cancer, and the incidence of melanoma, the deadliest form, continues to rise. Every day, 22 Canadians are diagnosed with melanoma, and 3 die from it. 'With one in three cancers diagnosed in Canada being skin cancer, access to timely follow-up care is crucial,' said Falyn Katz, CEO of Melanoma Canada. 'Our partnership with Rocket Doctor ensures that individuals flagged during our screenings, many of whom don't have a family doctor, can seamlessly transition from screening to care. It's a powerful step forward in improving outcomes for patients who might otherwise be left waiting.' The initiative is expected to increase patient traffic across Rocket Doctor's platform during Mole Mobile's national tour, while reinforcing Rocket Doctor's mission to improve equitable access to physician-led care. As part of the collaboration, Rocket Doctor's logo will also appear on Mole Mobile vans and campaign materials, which collectively generate millions of impressions throughout the tour. The term of this Agreement is 12 months commencing February 3, 2025, and will automatically renew for successive 12-month periods unless either party provides at least 30 days' written notice of termination prior to the renewal date. Initial events will kick off in Toronto and Edmonton this spring, with additional stops planned through October 2025. About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that empowers doctors to build and manage their own virtual or hybrid practices. Its proprietary software and AI-powered tools enable providers to deliver high-quality care remotely, with a focus on reaching underserved and remote communities across North America. By removing barriers to care and restoring physician autonomy, Rocket Doctor is redefining what modern healthcare looks like. Visit or contact media@ . About Melanoma Canada Melanoma Canada is a national organization dedicated to raising awareness, advancing prevention, and supporting patients affected by melanoma and skin cancer. Through programs like the Mole Mobile, Canada's first mobile skin cancer screening initiative, Melanoma Canada brings early detection, education, and hope to communities across the country. In partnership with Canadian dermatologists, the Mole Mobile has screened thousands of individuals and identified hundreds of potential skin cancers. Learn more at . About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact info@ . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: ehamza@ Media inquiries: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Hamilton Spectator
20-05-2025
- Health
- Hamilton Spectator
Rocket Doctor Partners with Melanoma Canada to Expand Access to Follow-Up Care for At-Risk Patients
New collaboration will connect patients flagged during mobile skin cancer screenings with Rocket Doctor physicians across Ontario, Alberta, and British Columbia ●Rocket Doctor has partnered with Melanoma Canada to provide timely follow-up care for patients identified as at-risk during mobile skin cancer screenings. ●Patients without a family doctor will be directly referred to physicians on Rocket Doctor through a streamlined digital intake process. ●The Mole Mobile campaign travels across Alberta, British Columbia, Ontario, and Quebec, providing free screenings in both remote and urban communities. ● Skin cancer is the most common cancer in Canada, with 1 in 3 cancer diagnoses being skin-related — more than breast, prostate, lung, and colon cancers combined. ● 22 Canadians are diagnosed with melanoma every day, and 3 Canadians die daily from this serious form of skin cancer. ●The partnership is expected to increase patient visits on Rocket Doctor's platform, improving access to care and continuity for at-risk individuals. Toronto, ON, May 20, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') is proud to announce that its virtual care subsidiary, Rocket Doctor Inc., has partnered with Melanoma Canada to help bridge the care gap for individuals identified as at-risk for melanoma and other skin cancers during mobile screening events across the country. Melanoma Canada's Mole Mobile units, Canada's first mobile skin cancer screening clinics, presented by Neutrogena®, a Kenvue brand travel across Alberta, British Columbia, Ontario, and Quebec, offering free skin checks from certified dermatologists in both remote and urban communities. Through this partnership, Rocket Doctor will provide patients who do not have a family physician with timely access to follow-up appointments via its virtual care platform. 'Too many Canadians are going without the care they need simply because they don't have a family doctor,' said Dr. William Cherniak, Founder and CEO of Rocket Doctor. 'By partnering with Melanoma Canada, we're making it easier for patients identified during these critical screenings to get connected to a physician quickly, ensuring no one falls through the cracks.' Dermatologists working in the Mole Mobile units will complete an on-site risk assessment and referral form for patients who require follow-up. These forms can then be uploaded directly to Rocket Doctor's intake system, enabling efficient, streamlined review and timely access to appropriate care. The need for follow-up care has never been more urgent. Skin cancer is the most commonly diagnosed cancer in Canada, more prevalent than breast, prostate, lung, and colon cancers combined. One in every three cancers diagnosed in Canada is a skin cancer, and the incidence of melanoma, the deadliest form, continues to rise. Every day, 22 Canadians are diagnosed with melanoma, and 3 die from it. 'With one in three cancers diagnosed in Canada being skin cancer, access to timely follow-up care is crucial,' said Falyn Katz, CEO of Melanoma Canada. 'Our partnership with Rocket Doctor ensures that individuals flagged during our screenings, many of whom don't have a family doctor, can seamlessly transition from screening to care. It's a powerful step forward in improving outcomes for patients who might otherwise be left waiting.' The initiative is expected to increase patient traffic across Rocket Doctor's platform during Mole Mobile's national tour, while reinforcing Rocket Doctor's mission to improve equitable access to physician-led care. As part of the collaboration, Rocket Doctor's logo will also appear on Mole Mobile vans and campaign materials, which collectively generate millions of impressions throughout the tour. The term of this Agreement is 12 months commencing February 3, 2025, and will automatically renew for successive 12-month periods unless either party provides at least 30 days' written notice of termination prior to the renewal date. Initial events will kick off in Toronto and Edmonton this spring, with additional stops planned through October 2025. About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that empowers doctors to build and manage their own virtual or hybrid practices. Its proprietary software and AI-powered tools enable providers to deliver high-quality care remotely, with a focus on reaching underserved and remote communities across North America. By removing barriers to care and restoring physician autonomy, Rocket Doctor is redefining what modern healthcare looks like. Visit or contact media@ . About Melanoma Canada Melanoma Canada is a national organization dedicated to raising awareness, advancing prevention, and supporting patients affected by melanoma and skin cancer. Through programs like the Mole Mobile, Canada's first mobile skin cancer screening initiative, Melanoma Canada brings early detection, education, and hope to communities across the country. In partnership with Canadian dermatologists, the Mole Mobile has screened thousands of individuals and identified hundreds of potential skin cancers. Learn more at . About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact info@ . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: ehamza@ Media inquiries: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Business Upturn
15-05-2025
- Health
- Business Upturn
Treatment.com AI and Rocket Doctor Applaud US Health Secretary RFK Jr.'s Call for Greater Investment in Telehealth and AI-Driven Diagnostic Tools
RFK Jr. calls for a 'revolution' in telehealth and AI to reduce ER visits and improve at-home care. AI and Rocket Doctor applaud the remarks, citing strong alignment with their mission. Rocket Doctor is currently empowering physicians to run their own practices in New York and California, serving Medicaid and Medicare patients in underserved communities. VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') and Rocket Doctor, its wholly owned online care platform, applaud United States Secretary of Health and Human Services, Robert F. Kennedy Jr., for his remarks during the House Appropriations Committee Budget Hearing yesterday, where he championed the potential role of telehealth and artificial intelligence in improving access to care. 'We are going to dramatically revolutionize the availability of telehealth and AI so that people can avoid emergency rooms by getting treated at home,' said Secretary Kennedy Jr. 'I looked at a technology yesterday that can accurately diagnose strep throat using your telephone camera with one picture of the inside of your throat…you can prevent somebody from having to go to the emergency room, and you can get them a prescription on site.' (see: Budget Hearing – U.S. Department of Health and Human Services – 2:12:25) These comments echo Treatment and Rocket Doctor's mission, and whose virtual care technologies are already making this future a reality. Across New York and California, Rocket Doctor's platform enables physicians to start their own practices and remotely diagnose and treat Medicare and Medicaid patients using advanced AI tools and Bluetooth-enabled medical devices. This service is providing patients in cities and rural communities with accurate, in-home assessments while reducing the need for emergency care visits. 'Virtual care is the great equalizer,' said Dr. William Cherniak, CEO and Founder of Rocket Doctor. 'Whether it's using a smartphone otoscope to examine an ear infection or a bluetooth connected stethoscope to assess lungs, we're equipping doctors and patients with the tools to make timely, accurate decisions from anywhere and anytime. Secretary Kennedy's remarks validate what we've been building: a healthcare model that is accessible for all people, where care comes to you.' He added 'As a practicing ER doctor I have seen first hand the challenges of patients using much more costly emergency services, when they could have safely been managed outside the four walls of the hospital. Our system is designed to address this problem, so far helping over 4,000 patients avoid emergency care at a hospital (see ) and subsequently we won Stanford's Emergency Medicine pitch contest for the innovative approach.' To further underscore its innovation, the American Telemedicine Association (ATA) recently announced Rocket Doctor as Clinical Innovator of the Year at its Innovators Challenge. Treatment further enhances this model through its proprietary Global Library of Medicine (GLM), a comprehensive, physician-developed AI engine that supports diagnosis and care planning. The GLM can be consumed in several ways, as examples powering health chatbots and voice agents, enabling intelligent patient onboarding and triage before any provider engagement. 'AI is offering the possibility to significantly impact healthcare for the 3 Ps: the Patient, the Provider, and the Payer,' said Dr. Essam Hamza, CEO of AI. 'It increases accuracy, improves workflow efficiency, and reduces unnecessary costs. What Secretary Kennedy described isn't hypothetical, it's happening now and we're proud to be at the forefront.' Together, Treatment and Rocket Doctor are demonstrating what's possible when technology, clinical expertise, and health system innovation align, helping patients avoid ER visits, shortening diagnostic timelines, and expanding access to high-quality care. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact [email protected]. About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that is breaking down obstacles that limit access to quality, comprehensive and cost-effective healthcare. Our proprietary software equips doctors with the tools to run successful practices in virtual and hybridized in-person/virtual models of care, enabling them to provide tailored care to patients in remote communities, particularly those in rural and Northern communities across Canada and on Medicaid in the United States. Leveraging large language models, AI/ML and wireless medical devices, Rocket Doctor is bridging the healthcare divide, connecting patients to equitable and accessible virtual healthcare services regardless of age, location, or financial status. This includes patients with potentially stigmatizing conditions such as substance use, mental health and otherwise. To learn more about Rocket Doctor's platform and services, visit (Canada) or (U.S.), or contact [email protected] . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: [email protected] Media inquiries: [email protected] Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although AI believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and AI undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
